Therefore, we first selected from the literature those loss-of-function mutations in HCN4 that have been associated with familial sinus bradycardia and for which both clinical and in vitro data are available, with the condition that the clinical data include quantitative heart rate data from at least two mutation carriers. Here, HCN4 is linked to Sinus bradycardia.